Expertise in
15
conditions

Dr. Tsewang Tashi

Hematology
Hematology-Hematologic - South Jordan
5126 W Daybreak Pkwy, 
South Jordan, UT 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
Hematology-Hematologic - South Jordan
5126 W Daybreak Pkwy, 
South Jordan, UT 

Overview

Tsewang Tashi is a Hematologist practicing medicine in South Jordan, Utah.

Dr. Tashi is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Polycythemia Vera, Mast Cell Activation Syndrome (MCAS), Essential Thrombocythemia, and Bone Marrow Aspiration.

Dr. Tashi is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 3 clinical trials. Dr. Tashi is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in VA

Board Certifications

American Board Of Internal Medicine

Hospital Affiliations

University Of Utah Hospital And Clinics

Languages Spoken

English
Mandarin

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Steward Health Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Hematology-hematologic - South Jordan
5126 W Daybreak Pkwy, South Jordan, UT 84009
Other Locations
Univ. Of Utah Hosp. Im-hematology-hematologic
1950 Circle Of Hope Dr, Salt Lake City, UT 84112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
Enrollment Status: Recruiting
Publish Date: August 04, 2026
Intervention Type: Drug
Study Drug: BLU-263
Study Phase: Phase 2/Phase 3
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2025
Intervention Type: Drug, Other
Study Drugs: Bosutinib, Dasatinib, Nilotinib, Nilotinib Hydrochloride Monohydrate, Ruxolitinib, Ruxolitinib Phosphate
Study Phase: Phase 2
Modulation of Morbidity and Disease Progression in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Patients With Obstructive Sleep Apnea (OSA) by CPAP
Modulation of Morbidity and Disease Progression in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Patients With Obstructive Sleep Apnea (OSA) by CPAP
Enrollment Status: Terminated
Publish Date: January 08, 2024
Intervention Type: Procedure, Other
Study Phase: Early Phase 1
View 2 Less Clinical Trial

38 Total Publications

Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system.
Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system.
Journal: Cancer treatment and research communications
Published: June 10, 2026
Similar Doctors
Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required
2000 Cir of Hope Dr, 
Salt Lake City, UT 
 (18.5 miles away)
801-585-3229
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Narendranath Epperla is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Epperla is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is board certified in American Board Of Internal Medicine. Dr. Epperla is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Univ. Of Utah Hosp. Im-Hematology-Hematologic

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 (18.5 miles away)
801-585-3229
Languages Spoken:
English, Czech, German, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Josef Prchal is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Prchal is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is board certified in American Board Of Internal Medicine. Dr. Prchal is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Huntsman Cancer Institute Bmt

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 (18.5 miles away)
801-585-2626
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Sborov is a Hematologist practicing medicine in Salt Lake City, Utah. He has been practicing medicine for over 17 years. Dr. Sborov is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Sborov is board certified in American Board Of Internal Medicine. Dr. Sborov is currently accepting new patients.

Frequently Asked Questions about Dr. Tsewang Tashi

How do I make an appointment with Dr. Tsewang Tashi?

You can book an appointment with Dr. Tsewang Tashi by calling their office at 801-213-4500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Tsewang Tashi a top-rated expert for Systemic Mastocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tsewang Tashi is classified as an Elite expert for Systemic Mastocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Tsewang Tashi specialize in?

While Dr. Tsewang Tashi is a Hematology, they have specific expertise in Systemic Mastocytosis, Polycythemia Vera, and Mast Cell Activation Syndrome (MCAS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Tsewang Tashi participate in research or clinical trials?

Yes. Dr. Tsewang Tashi has published 38 articles and abstracts on conditions like Systemic Mastocytosis. You can view a list of Dr. Tsewang Tashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Tsewang Tashi accept my insurance?

Dr. Tsewang Tashi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-213-4500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tashi's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile